ATHA
Price:
$6.75
Market Cap:
$33.21M
Athira Pharma, Inc., a biopharmaceutical firm in advanced clinical development and based in Bothell, Washington, focuses on creating small molecule treatments designed to revitalize neuronal function and decelerate neurological decline. Its primary therapeutic candidate, ATH-1017, is a unique small molecule that modulates HGF/MET and is capable of crossing the blood-brain barrier. This compound is currently undergoing a Phase 3 clinical trial (LIFT-AD) and a Phase 2 clinical trial (ACT-AD) for Alzheimer's disease. Additionally, ATH-1017 is in Phase 2 clinical trials for Parkinson's disease. The company also has several product candidates in earlier, preclinical stages of development, includi...[Read more]
Industry
Biotechnology
IPO Date
2020-09-18
Stock Exchange
NASDAQ
Ticker
ATHA
According to Athira Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.07M. This represents a change of -112.19% compared to the average of -8747970.55 of the last 4 quarters.
The mean historical Enterprise Value of Athira Pharma, Inc. over the last ten years is 313.35M. The current 1.07M Enterprise Value has changed -65.96% with respect to the historical average. Over the past ten years (40 quarters), ATHA's Enterprise Value was at its highest in in the December 2020 quarter at 1.05B. The Enterprise Value was at its lowest in in the September 2024 quarter at -50363150.40.
Average
313.35M
Median
199.01M
Minimum
-36105481.66
Maximum
1.05B
Discovering the peaks and valleys of Athira Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 88.84%
Maximum Annual Enterprise Value = 1.05B
Minimum Annual Increase = -826.62%
Minimum Annual Enterprise Value = -36105481.66
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -36105481.66 | 46.58% |
| 2024 | -24632723.44 | -826.62% |
| 2023 | 3.39M | -86.74% |
| 2022 | 25.56M | -93.14% |
| 2021 | 372.47M | -64.63% |
| 2020 | 1.05B | 88.84% |
| 2019 | 557.61M | 0.38% |
The current Enterprise Value of Athira Pharma, Inc. (ATHA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-19116055.90
5-year avg
68.14M
10-year avg
313.35M
Athira Pharma, Inc.’s Enterprise Value is less than Leap Therapeutics, Inc. (30.18M), less than Citius Pharmaceuticals, Inc. (2.25M), greater than SeaStar Medical Holding Corporation (-559927.00), less than Apollomics, Inc. (13.15M), less than Moleculin Biotech, Inc. (3.96M), greater than Curis, Inc. (-8118049.00), less than FibroBiologics, Inc. Common Stock (2.70M), less than Lunai Bioworks Inc. (9.18M), less than Aditxt, Inc. (3.97M), less than Daré Bioscience, Inc. (7.90M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 30.18M | $31.86M | |
| 2.25M | $6.03M | |
| -559927.00 | $8.46M | |
| 13.15M | $15.78M | |
| 3.96M | $14.09M | |
| -8118049.00 | $5.55M | |
| 2.70M | $1.95M | |
| 9.18M | $10.93M | |
| 3.97M | $425.00 | |
| 7.90M | $19.23M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Athira Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Athira Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Athira Pharma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Athira Pharma, Inc. (ATHA)?
What is the 3-year average Enterprise Value for Athira Pharma, Inc. (ATHA)?
What is the 5-year average Enterprise Value for Athira Pharma, Inc. (ATHA)?
How does the current Enterprise Value for Athira Pharma, Inc. (ATHA) compare to its historical average?